Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting

New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21 Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR⍺)-targeting antibody-drug conjugate (ADC) New ADC candidates, including ZW437 and ZW418, demonstrate strong activity across RAS-mutated cancers based on a novel pan-RAS inhibitor ADC platform […]


22 h.
Science
ID: 9200595581608013640


Similar News expand_more


Technology
Technology
Science
Science
Technology
Education
Technology
Science
Technology
Technology
Technology
Science
Science
Technology
Technology
Science
Politics
Technology
Technology
Science
Technology
Technology
Science
Science
Science
Science
Education
Economics
Technology
Technology
Education
Science
Science
Science
Economics
Technology
Science
Technology
Technology
Technology
Culture
Technology
Politics
Technology
Science
Crime
Education
Technology
Technology
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down